GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (FRA:940) » Definitions » Revenue

Euroapi (FRA:940) Revenue : €919.2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Revenue?

Euroapi's revenue for the six months ended in Dec. 2024 was €468.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €919.2 Mil. Euroapi's Revenue per Share for the six months ended in Dec. 2024 was €4.95. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €9.65.

Warning Sign:

Euroapi SA revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Euroapi was -8.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, Euroapi's highest 3-Year average Revenue per Share Growth Rate was 2.00% per year. The lowest was 0.80% per year. And the median was 1.90% per year.


Euroapi Revenue Historical Data

The historical data trend for Euroapi's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Revenue Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial 944.60 892.80 980.90 1,018.90 919.20

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 495.10 498.50 520.40 450.90 468.30

Competitive Comparison of Euroapi's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroapi's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Revenue distribution charts can be found below:

* The bar in red indicates where Euroapi's Revenue falls into.


;
;

Euroapi Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €919.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroapi  (FRA:940) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Euroapi Revenue Related Terms

Thank you for viewing the detailed overview of Euroapi's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.

Euroapi Headlines

No Headlines